Investor FAQs

Investor FAQs

Show All
Where is Surface Oncology headquartered?
Surface Oncology is headquartered at 50 Hampshire Street in Cambridge, Massachusetts.
When was the company founded?
Surface Oncology was initially seeded by Atlas Venture in 2014.
When did Surface Oncology go public?
Our shares began trading on the Nasdaq Global Market on April 19, 2018.
What exchange is Surface Oncology stock listed on? What is the ticker symbol for Surface Oncology?
Shares of Surface Oncology stock are traded on the Nasdaq Global Market under the symbol “SURF.”
What is Surface Oncology’s CUSIP number?
86877M 100.
Where is Surface Oncology incorporated?
We were incorporated under the laws of the State of Delaware in April 2014.
When is Surface Oncology’s fiscal year-end?
Surface Oncology’s fiscal year ends on December 31st.
Who are Surface Oncology’s independent auditors?
PricewaterhouseCoopers, LLP
1 Broadway, 14th Floor
Cambridge, MA 02142
(617) 530-5000
Who are Surface Oncology’s outside legal counsel?
Goodwin Procter, LLP
100 Northern Avenue
Boston, MA 02210
(617) 266-2000
Who is Surface Oncology’s transfer agent?
Computershare
PO Box 505000
Louisville, KY 40233
Where can I get the latest corporate news releases?
Surface Oncology’s press releases can be viewed at https://investors.surfaceoncology.com/news-events/press-releases.
Where can I find Surface Oncology’s SEC filings?
Surface Oncology’s SEC filings can be found on the Financial Information portion of our website.
Whom should I contact if I have future questions?
You can submit questions to Surface Oncology’s investor relations department by contacting IR@surfaceoncology.com.